Vepafestinib (TAS0953) | RET inhibitor | Probechem Biochemicals

Chemical Structure : Vepafestinib

CAS No.: 2129515-96-2

加入收藏

Vepafestinib (TAS0953, TAS-0953, HM06)

货号: PC-38426Not For Human Use, Lab Use Only.

Vepafestinib (TAS0953, HM06) is a next-generation RET inhibitor, potently inhibits recombinant WT RET kinase with IC50 of 0.33 nM, targets RET wild-type (WT) kinase and RET solvent front mutants (RETL730, RETV804 and RETG810).

规格	价格	库存
5 mg	￥2580	In stock
10 mg	￥3880	In stock
25 mg	￥5980	In stock
100 mg		Get quote

获取报价单

* 请选择数量再加入购物车

or Bulk Inquiry

大包装，大折扣！

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

生物&药学活性

Vepafestinib (TAS0953, HM06) is a next-generation RET inhibitor, potently inhibits recombinant WT RET kinase with IC50 of 0.33 nM, targets RET wild-type (WT) kinase and RET solvent front mutants (RETL730, RETV804 and RETG810).

Vepafestinib (TAS0953, HM06) displays excellent kinase selectivity against a panel of 255 recombinant kinases.

Vepafestinib (TAS0953, HM06) potently inhibits growth of Ba/F3 cells expressing KIF5B–RETWT or KIF5B–RET mutants (V804M, V804L, G810R, G810S, G810C), but not selpercatinib and pralsetinib.

Vepafestinib (TAS0953, HM06) suppresses phosphorylation of RETG810R, RETG810S and RETG810C with near-complete inhibition at 100 nM in Ba/F3 KIF5B–RETWT cells, but not selpercatinib and pralsetinib.

Vepafestinib (TAS0953, HM06) inhibits transmission of signals and blocks growth of cells with RET alterations, effectively inhibits cell growth of HBECp53-RET (CCDC6-RET fusion; IC50 = 60 nM), with little effect on the isogenic control HBECp53-EV cells.

Vepafestinib (TAS0953, HM06) modulates expression of cell cycle and apoptosis markers.

Vepafestinib (TAS0953, HM06) treatment (50 mg per kg BID and 100 mg per kg, once daily (QD)) caused significant reductions in ECLC5B xenograft tumor growth, shows anti-tumor activity against KIF5B–RETG810R-driven allograft tumors.

Vepafestinib (TAS0953, HM06) is more effective than selpercatinib at penetrating the brain and blocking intracranial tumor growth.

物理化学性质&存储条件

分子量	474.565
分子式	C26H30N6O3
外观性状	Solid
CAS No.
储存条件	固体粉末 -20°C 12 个月; 4°C 6 个月	配置液 -80°C 6 个月; -20°C 6 个月
Shipping
Solubility	10 mM in DMSO
Chemical Name/SMILES	4-amino-N-(4-(methoxymethyl)phenyl)-7-(1-methylcyclopropyl)-6-(3-morpholinoprop-1-yn-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide

参考文献

1. Patent WO2017146116 A1.

Vepafestinib (TAS0953, TAS-0953, HM06)

生物&药学活性

物理化学性质&存储条件

参考文献

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

询单

Vepafestinib (TAS0953, TAS-0953, HM06)

生物&药学活性

物理化学性质&存储条件

参考文献

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

询单

Get Quotation Now

* Indicates a Required FieldYour information is safe with us.